PedAM
Pediatric Disease Annotations & Medicines
| Disease | c syndrome |
| Phenotype | C0002395|alzheimer\'s disease |
| Sentences | 7 |
| PubMedID- 20537736 | Prevalence of neuropsychiatric syndromes in alzheimer's disease (ad). |
| PubMedID- 21559196 | Finally, when ad patients were subdivided according to the european alzheimer's disease consortium classification of neuropsychiatric syndromes, for the affective syndrome (i.e., ad patients with the npi symptoms depression and anxiety), these previous findings in ad and demented patients [27, 73, 74] were confirmed suggesting that the presence of an apoe ε4 allele may be a risk factor also for anxiety symptoms [56]. |
| PubMedID- 21457772 | The role of iron in catalyzing fenton-mediated oxidative damage has been implicated in iron overload genetic diseases, carcinogenesis (colon cancer), alzheimer's disease and complications associated with the metabolic syndrome through the generation of reactive oxygen species (ros). |
| PubMedID- 25191597 | alzheimer's disease has beenassociated with the metabolic syndrome in humans(14) and wistar kyoto rats fed a hfd show increases in the levels ofbiomarkers for alzheimer's disease(15). |
| PubMedID- 20383813 | Hyperhomocysteinemia and homozygous mthfr 677c>t mutation finding in an alzheimer's disease case with metabolic syndrome diagnosis. |
| PubMedID- 21726644 | Although the enhanced risk of alzheimer's disease in metabolic syndrome is related to several factors, our results suggest that srebp2, which can be modulated by the impairment of cerebral cholesterol homeostasis, has a direct role on bace1 expression and may be involved in alzheimer's disease progression. |
| PubMedID- 23142434 | Background: accumulating evidence indicates an association of alzheimer's disease (ad) with the metabolic syndrome (mets), characterized by visceral fat accumulation with insulin resistance and altered secretion of adipocytokines such as adiponectin and leptin. |
Page: 1